Gemifloxacin mesylate |
Factive |
Clinical Trial: A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children with Prior Treatment
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to determine the value of changing anti-HIV medications in children with progressive HIV disease who have received previous treatment. Plasma viral load (the level of HIV in the blood) is probably most effectively reduced by giving patients anti-HIV drugs which affect the virus at various stages of development. Changing the medications may enhance the results of treatment.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| HIV Infections | Drug: Ritonavir Drug: Nelfinavir mesylate Drug: Nevirapine Drug: Lamivudine Drug: Stavudine Drug: Zidovudine Drug: Zalcitabine Drug: Didanosine | Phase I |
MedlinePlus related topics: AIDS
Study Type: Interventional
Study Design: Treatment, Pharmacokinetics Study
Official Title: RAD-1: A Phase I/II Antiretroviral Management Algorithm for Pediatric Subjects of Four-Drug Combination Therapies Based on Prior Antiretroviral Experience
Expected Total Enrollment: 200
The Master RAD Protocol is based on the concept that optimal suppression of viral load in vivo will be achieved in patients with rapidly progressing or advanced HIV disease (RAD) using antiretroviral combinations inhibiting viral replication at distinct sites of action. Antiretroviral combinations are chosen with the hypothesis that simultaneous change to as many new agents as possible is necessary to maximally reduce plasma viral load.
In this open-label, multicenter study patients are randomized into 1 of 4 groups based on prior antiretroviral experience. Each regimen consists of 4 drugs that include a combination of nucleoside reverse transcriptase inhibitors (stavudine, lamivudine, zidovudine, didanosine, zalcitabine) plus nevirapine (NVP), nelfinavir (NFV), or ritonavir (RTV). Patients must be naive to at least 2 of the 4 drugs in the regimen and at least 1 of the novel drugs must be NVP, NFV, or RTV. Prior to randomization to a NFV- or RTV-containing regimen, patients are stratified by HIV RNA (greater than or equal to 50,000 or less than 50,000) and must able to receive 2 or more novel drugs.
Eligibility
Ages Eligible for Study: 6 Months - 21 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria
Your child may be eligible for this study if he or she:
- Is HIV-positive.
- Is between the ages of 6 months and 21 years (consent of parent or guardian required if under 18).
- Has an HIV blood level above 50,000 copies/mL on 2 consecutive occasions, while taking anti-HIV therapy.
- Has advanced HIV disease or disease progression while receiving 8 weeks or more of continuous unchanged anti-HIV therapy.
- Is able to receive at least one of the following: RTV, NVP, or NFV.
Exclusion Criteria
Your child will not be eligible for this study if he or she:
- Is receiving treatment for a serious bacterial, viral, or opportunistic (HIV-associated) infection within 14 days prior to study entry.
- Has a history of pancreatitis or peripheral neuropathy.
- Has cancer requiring chemotherapy.
- Is allergic to the study medications.
- Is taking certain medications.
- Is pregnant.
Location Information
Alabama
Univ of South Alabama, Mobile, Alabama, 36604, United States
Univ of Alabama at Birmingham - Pediatric, Birmingham, Alabama, 35233, United States
California
UCSF / Moffitt Hosp - Pediatric, San Francisco, California, 941430105, United States
UCSD Med Ctr / Pediatrics / Clinical Sciences, La Jolla, California, 920930672, United States
Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, 905022004, United States
Children's Hosp of Oakland, Oakland, California, 946091809, United States
Cedars Sinai / UCLA Med Ctr, Los Angeles, California, 900481804, United States
Long Beach Memorial (Pediatric), Long Beach, California, 90801, United States
Los Angeles County - USC Med Ctr, Los Angeles, California, 90033, United States
Colorado
Children's Hosp of Denver, Denver, Colorado, 802181088, United States
Connecticut
Yale Univ Med School, New Haven, Connecticut, 06504, United States
Connecticut Children's Med Ctr, Farmington, Connecticut, 060303805, United States
District of Columbia
Howard Univ Hosp, Washington, District of Columbia, 20060, United States
Florida
Univ of Miami (Pediatric), Miami, Florida, 33161, United States
Univ of Florida Health Science Ctr / Pediatrics, Jacksonville, Florida, 32209, United States
North Broward Hosp District, Fort Lauderdale, Florida, 33311, United States
Georgia
Emory Univ Hosp / Pediatrics, Atlanta, Georgia, 30306, United States
Med College of Georgia, Augusta, Georgia, 30912, United States
The Med Ctr Inc, Columbus, Georgia, 31901, United States
Illinois
Chicago Children's Memorial Hosp, Chicago, Illinois, 606143394, United States
Cook County Hosp, Chicago, Illinois, 60612, United States
Univ of Illinois College of Medicine / Pediatrics, Chicago, Illinois, 60612, United States
Louisiana
Tulane Univ / Charity Hosp of New Orleans, New Orleans, Louisiana, 701122699, United States
Maryland
Univ of Maryland at Baltimore / Univ Med Ctr, Baltimore, Maryland, 21201, United States
Johns Hopkins Hosp - Pediatric, Baltimore, Maryland, 212874933, United States
Massachusetts
Children's Hosp of Boston, Boston, Massachusetts, 021155724, United States
Boston City Hosp / Pediatrics, Boston, Massachusetts, 02118, United States
Baystate Med Ctr of Springfield, Springfield, Massachusetts, 01199, United States
Univ of Massachusetts Med School, Worcester, Massachusetts, 016550001, United States
Mississippi
Univ of Mississippi Med Ctr, Jackson, Mississippi, 39213, United States
New Jersey
Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark, New Jersey, 071032714, United States
UMDNJ - Robert Wood Johnson Med School / Pediatrics, New Brunswick, New Jersey, 089030019, United States
Saint Joseph's Hosp and Med Ctr/UMDNJ - New Jersey Med Schl, Newark, New Jersey, 07103, United States
New York
Harlem Hosp Ctr, New York, New York, 10037, United States
SUNY - Brooklyn, Brooklyn, New York, 11203, United States
Cornell Univ Med College, New York, New York, 10021, United States
North Shore Univ Hosp, Great Neck, New York, 11021, United States
Schneider Children's Hosp, New Hyde Park, New York, 11040, United States
Bellevue Hosp / New York Univ Med Ctr, New York, New York, 10016, United States
Columbia Presbyterian Med Ctr, New York, New York, 10032, United States
Metropolitan Hosp Ctr, New York, New York, 10029, United States
Children's Hosp at Albany Med Ctr, Albany, New York, 12208, United States
SUNY Health Sciences Ctr at Syracuse / Pediatrics, Syracuse, New York, 13210, United States
Bronx Lebanon Hosp Ctr, Bronx, New York, 10457, United States
Incarnation Children's Ctr / Columbia Presbyterian Med Ctr, New York, New York, 10032, United States
State Univ of New York at Stony Brook, Stony Brook, New York, 117948111, United States
Univ of Rochester Med Ctr, Rochester, New York, 146420001, United States
North Carolina
Duke Univ Med Ctr, Durham, North Carolina, 277103499, United States
Univ of North Carolina at Chapel Hill / Duke Univ Med Ctr, Durham, North Carolina, 27710, United States
Ohio
Columbus Children's Hosp, Columbus, Ohio, 432052696, United States
Pennsylvania
Children's Hosp of Philadelphia, Philadelphia, Pennsylvania, 191044318, United States
Saint Christopher's Hosp for Children, Philadelphia, Pennsylvania, 191341095, United States
South Carolina
Med Univ of South Carolina, Charleston, South Carolina, 294253312, United States
Tennessee
Saint Jude Children's Research Hosp of Memphis, Memphis, Tennessee, 381052794, United States
Vanderbilt Univ Med Ctr, Nashville, Tennessee, 372322581, United States
Texas
Children's Med Ctr of Dallas, Dallas, Texas, 75235, United States
Texas Children's Hosp / Baylor Univ, Houston, Texas, 77030, United States
Virginia
Children's Hosp of the King's Daughters, Norfolk, Virginia, 23507, United States
Med College of Virginia, Richmond, Virginia, 23219, United States
Puerto Rico
San Juan City Hosp, San Juan, 009367344, Puerto Rico
Univ of Puerto Rico / Univ Children's Hosp AIDS, San Juan, 009365067, Puerto Rico
Ramon Ruiz Arnau Univ Hosp / Pediatrics, Bayamon, 00956, Puerto Rico
Andrea Kovacs, Study Chair
Sandra Burchett, Study Chair
More Information
Click here for more information about Zidovudine
Click here for more information about Zalcitabine
Click here for more information about Didanosine
Click here for more information about Stavudine
Click here for more information about Nevirapine
Click here for more information about Lamivudine
Click here for more information about Ritonavir
Click here for more information about Nelfinavir mesylate
Haga clic aquí para ver información sobre este ensayo clínico en español.
Publications
Weinberg A, Kovacs A, Pahwa S, Carey V, Oyomopito R, Mofenson L, Khoury M, Zimmer B, Burchett S. HIV-infected children on HAART reconstitute tetanus-specific T cell responses without booster vaccination. 8th Conf Retro and Opportun Infect. 2001 Feb 4-8 (abstract no 688)
Frenkel LM, Burchett SK, Aldrovandi GM, Carey V, Oyomopito R, Mahalanibis M, Decker D, Kovacs A. HIV-1 reverse transcriptase (RT) M184V/I improves the rate of suppression of viral replication by salvage therapy. 8th Conf Retro and Opportun Infect. 2001 Feb 4-8 (abstract no 463)
Kovacs A, Burchett S, Khoury M, Carey V, Pahwa S, McIntosh K, Oyomopito R, Smith E, Mofenson L. Virologic and immunologic responses in children with advanced HIV disease on a new HAART regimen (PACTG 366). 8th Conf Retro and Opportun Infect. 2001 Feb 4-8 (abstract no 684)
Record last reviewed: August 2004
Last Updated: April 7, 2005
Record first received: November 2, 1999
ClinicalTrials.gov Identifier: NCT00000902
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


